Visivite Supplements for Macular Degeneration
Visivite are vitamins for the eyes. In a study conducted at 11 major medical center research facilities around the country revealed that the ingredients in Visivite were able to slow the progression of macular degeneration in patients with intermediate or advanced disease. The anti-oxidants and zinc in the supplement promote the health of the retina and tissues surrounding the retina. Visivite is not your everyday common multi-vitamin, rather, Visivite contains high levels of supplement and those substances are proven to promote retinal health.
What is macular degeneration. It is an eye condition when the macula is damaged. The macula is a sensitive area in the retina responsible for central & detail vision. Macular degeneration often causes loss of central vision. There are two types of macular degeneration, dry & wet form. The dry form usually progresses slowly and causes central vision loss while the wet form are more severe and may progress quickly causing significant central vision loss. Macular degeneration are more proned to people over the age of 60 but can also happen to those as young as 40. As far as the cause of macular degeneration, there is no conclusive proof as to the main cause but it is believed that heredity may play a part as may UV light and malnutrition.
There are 5 different formulas that Visivite provides, e-free which is the original, yellow, gold, red and green. The original formula is for those who want to duplicate the AREDS (age related eye disease study) formula. Take the yellow formula if you do not have a history of habitual smoking and have stable macular degeneration. The red formula is for people who have a history of smoking and have stable macular degeneration. If you do not have a history of smokng & have progressive or severe macular dengeration, then a stronger vitamin supplement for you to take would be the gold formula. Finally, the green formula which is the strongest is catered to those who have a history of habitual smoking and have progressive or severe macular degeneration.